Tag: Pharma acquisition news
Cipla to acquire Actor Pharma to dominate South African OTC market
In a strategic move that amplifies its commitment to the Over-The-Counter (OTC) business, Cipla South Africa, a 100% owned subsidiary of Cipla Limited (BSE: 500087; ... Read More
Novo Nordisk acquires Embark Biotech and enters R&D collaboration to advance obesity treatments
Novo Nordisk, a global leader in healthcare, has acquired Embark Biotech, including its lead metabolic program, in a deal that further strengthens its portfolio in ... Read More
Lilly expands portfolio with $1.9bn acquisition of Versanis Bio
In a move marking a significant expansion in the biopharmaceutical sector, Eli Lilly and Company (Lilly) has successfully completed the acquisition of Versanis Bio, a ... Read More
Lilly wraps up Sigilon Therapeutics acquisition to amplify Type 1 diabetes research
Eli Lilly and Company (Lilly) has formally announced the culmination of its $309.6 million takeover of biopharma trailblazer, Sigilon Therapeutics, Inc. (NASDAQ: SGTX). This strategic ... Read More
Novartis acquires kidney disease innovator Chinook Therapeutics
Swiss pharmaceutical giant Novartis has wrapped up the previously announced $3.5 billion acquisition of Seattle-based biopharmaceutical firm Chinook Therapeutics, Inc. This deal propels Novartis deeper ... Read More
Novo Nordisk to acquire Canadian pharma company Inversago Pharma
Danish pharma major Novo Nordisk A/S has confirmed its plan to acquire Montreal-based Inversago Pharma. The potential cash deal, reaching up to $1.075 billion, hinges ... Read More
Biogen to expand portfolio with $7.3bn acquisition of Reata Pharmaceuticals
Biogen Inc. (Nasdaq: BIIB) is set to acquire Reata Pharmaceuticals, Inc. (Nasdaq: RETA) for $172.5 per share in cash, amounting to an enterprise value of ... Read More
Roquette to acquire Qualicaps to boost position in pharma industry
Roquette, a supplier of plant-based ingredients and pharmaceutical excipients, is set to acquire Qualicaps, further reinforcing its position within the pharmaceutical industry. The merger of ... Read More
AstraZeneca’s Alexion to boost rare disease commitment with Pfizer’s gene therapy programs
Alexion, a subdivision of AstraZeneca focusing on rare diseases, has announced its definitive purchase and licensing agreement for a portfolio of preclinical gene therapy programmes ... Read More
Sosei Group acquires Idorsia’s Japanese and Korean pharma units
Sosei Group Corporation has announced its decision to acquire all shares of Idorsia Pharmaceuticals Japan Ltd ("IPJ") and Idorsia Pharmaceuticals Korea Co., Ltd ("IPK") from ... Read More